Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing related to the company's dematerialised (demat) share holdings. Such certificates are typically issued by the company's Registrar and Share Transfer Agent and confirm that share-related records held with depositories are in order. No new financial information, share issuance, or corporate action is involved. The filing is part of periodic regulatory disclosures expected from listed companies.
This is a standard procedural compliance filing with no material effect on the company's financials, operations, or share price. Shareholders need not take any action.